Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer

Cell Proliferation

Volumn 45, Issue 3, 2012, Pages 217-224

  Wen, X ^a   Lin, Z Q ^a   Liu, B ^a   Wei, Y Q ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BECLIN 1; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CYTOCHROME C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR; FAS LIGAND; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER GROWTH; CANCER THERAPY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; MOLECULAR INTERACTION; MOLECULARLY TARGETED THERAPY; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CASPASES; CYTOCHROMES C; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MEMBRANE PROTEINS; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; SUBSTRATE SPECIFICITY;

HARNESS; INTRACISTERNAL A-PARTICLES;

EID: 84862815471     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2012.00814.x     Document Type: Article

References (62)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
2. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407, 770-776.
3. Kurokawa M, Kornbluth S (2009) Caspases and kinases in a death grip. Cell 138, 838-854.
4. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75, 641-652.
5. Degterev A, Boyce M, Yuan J (2003) A decade of caspases. Oncogene 22, 8543-8567.
6. Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 55, 178-194.
7. Li J, Yuan J (2008) Caspases in apoptosis and beyond. Oncogene 27, 6194-6206.
8. Cho DH, Jo YK, Hwang JJ, Lee YM, Roh SA, Kim JC (2009) Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis in HeLa cells. Cancer Lett. 274, 95-100.
9. Jeong HS, Choi HY, Lee ER, Kim JH, Jeon K, Lee HJ et al. (2010) Involvement of caspase-9 in autophagy-mediated cell survival pathway. Biochim. Biophys. Acta 1813, 80-90.
10. Li ZY, Yang Y, Ming M, Liu B (2011) Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun. 414, 5-8.
11. Philchenkov A (2004) Caspases: potential targets for regulating cell death. J. Cell Mol. Med. 8, 432-444.
12. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J et al. (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL Receptors 1 and 2 and are essential for apoptosis mediated by TRAIL Receptor 2. Immunity, 12, 599-609.
13. Krammer PH (1999) CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71, 163-210.
14. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH et al. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588.
15. Ivano A, Gerry M, Richard AK (2011) Cell death pathology: cross-talk with autophagy and its clinical implications. Biochem. Biophys. Res. Commun. 414, 277-281.
16. Deveraux QL, Roy N, Stennicke HR, Arsdale TV (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215-2223.
17. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH et al. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 2794-2804.
18. Sun S (2011) Understanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer Metastasis. Mol. Cell. Pharmacol. 3, 31-34.
19. Huang Z (2000) Bcl-2 family proteins as targets for anticancer drug design. Oncogene 19, 6627-6631.
20. Chipuk JE, Green DR (2008) How do BCL-2 proteins induce mitochondrial outer membrane permeabilization. Trends Cell Biol. 18, 157-164.
21. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
22. Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M et al. (2009) Caspase genes apoptosis and cancer: mutations within caspase genes. J. Med. Genet. 46, 497-510.
23. Kuida K, Haydar TF, Kuan CY et al. (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase-9. Cell 94, 325-337.
24. Martin MC, Allan LA, Lickrish M, Sampson C, Morrice N, Clarke PR (2005) Protein kinase A regulates caspase-9 activation by Apaf-1 downstream of cytochrome c. J. Biol. Chem. 280, 15449-15455.
25. Allan LA, Clarke PR (2009) Apoptosis and autophagy: regulation of caspase-9 by phosphorylation. FEBS J. 276, 6063-6073.
26. Shai WG, David TK, Christina VJ (2009) The role of protein synthesis in cell cycling and cancer. Mol. Oncol. 3, 402-408.
27. Srinivasula SM, Ashwell JD (2008) IAPs: what's in a name? Mol. Cell 30, 123-135.
28. Altieri DC (2010) Survivin and IAP proteins in cell-death mechanisms. Biochem. J. 430, 199-205.
29. Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM et al. (2003) Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell 11, 519-527.
30. Shi Y (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459-470.
31. Chen M, Wang J (2002) Initiator caspases in apoptosis signaling pathways. Apoptosis 7, 313-319.
32. Liu B, Cheng Y, Liu Q, Bao JK, Yang JM (2010) Autophagic pathways as new targets for cancer drug development. Acta Pharmacol. Sin. 31, 1154-1164.
33. Wirawan E, Vande Walle L, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I et al. (2010) Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of pro-apoptotic factors from mitochondria. Cell Death Dis. 1, e18.
34. L. Cell Death Differ. 17, 268-277.
35. Djavaheri-Mergny M, Maiuri MC, Kroemer G (2010) Cross-talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin-1. Oncogene 29, 1717-1719.
36. Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L et al. (2006) H-U Simon, Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol. 8, 1124-1132.
37. Zalckvar E, Yosef N, Reef S, Ber Y, Rubinstein AD, Mor I et al. (2010) A systems level strategy for analyzing the cell death network: implication in exploring the apoptosis/autophagy connection. Cell Death Differ. 17, 1244-1253.
38. Betin VM, Lane JD (2009) Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J. Cell Sci. 122, 2554-2566.
39. Bell BD, Leverrier S, Weist BM, Newton RH, Arechiga AF, Luhrs KA et al. (2008) FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc. Natl. Acad. Sci. USA. 105, 16677-16682.
40. Wang SY, Yu QJ, Zhang RD, Liu B (2011) Core signaling pathways of survival/death in autophagy-related cancer networks. Int. J. Biochem. Cell Biol. 4, 1263-1266.
41. Stupack DG (2010) Caspase-8 as a therapeutic target in cancer. Cancer Lett. doi: 10.1016/j.canlet.2010.07.022
42. Mielgo A, Torres VA, Clair K, Barbero S, Stupack DG (2009) Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules. Oncogene 28, 3551-3562.
43. Chen C, Liu Y, Zheng D (2009) An agonistic monoclonal antibody against DR5 induces ROS production, sustained JNK activation and endo G release in Jurkat leukemia cells. Cell Res. 19, 984-995.
44. Kelleher ZT, Matsumoto A, Stamler JS, Marshall HE (2007) NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J. Biol. Chem. 282, 30667-30672.
45. Chauhan D, Singh A, Brahmandam M et al. (2008) Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma. Blood 111, 1654-1664.
46. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N (2000) Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 60, 4315-4319.
47. Raguénez G, Mühlethaler-Mottet A, Meier R, Duros C, Bénard J, Gross N (2009) Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma. BMC Cancer 9, 97.
48. Kalli KR, Devine KE, Cabot MC, Arnt CR, Heldebrant MP, Svingen PA et al. (2003) Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines. Mol. Pharmacol. 64, 1434-1443.
49. Nör JE, Hu Y, Song W, Spencer DM, Núñez G (2002) Ablation of microvessels in vivo upon dimerization of iCaspase-9. Gene Ther. 9, 444-451.
50. Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D et al. (1999) RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397, 534-539.
51. Liu JJ, Lin M, Yu JY, Liu B, Bao JK (2011) Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett. 300, 105-114.
52. Shariat SF, Desai S, Song W, Khan T, Zhao J, Nguyen C et al. (2001) Adenovirus-mediated transfer of inducible caspases: a novel 'death switch' gene therapeutic approach to prostate cancer. Cancer Res. 61, 2562-2571.
53. Lou GG, Yao HP, Xie LP (2010) Brucea javanica oil induces apoptosis in T24 bladder cancer cells via upregulation of caspase-3, caspase-9, and inhibition of NF-kappa B and COX-2 expressions. Am. J. Chin. Med. 38, 613-624.
54. Kim BM, Maeng K, Lee KH, Hong SH (2011) Combined treatment with the Cox-2 inhibitor niflumic acid and PPARγ ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells. Cancer Lett. 300, 134-144.
55. Li X, Su B, Liu R, Wu D, He D (2011) Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J. Surg. Res. 166, e45-e51.
56. Ljungman M (2009) Targeting the DNA damage response in cancer. Chem. Rev. 109, 2929-2950.
57. Miwa M, Masutani M (2007) Poly (ADP-ribosyl) ation and cancer. Cancer 98, 1528-1535.
58. White AW, Almassy R, Calvert AH, Curtin NJ, Griffin RJ, Hostomsky Z et al. (2000) Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. J. Med. Chem. 43, 4084-4097.
59. Ferraris DV (2010) Evolution of poly (ADP-ribose) polymerase-1(PARP-1) inhibitors. from concept to clinic. J. Med. Chem. 53, 4561-4584.
60. Loh VM Jr, Cockcroft XL, Dillon KJ, Dixon L, Drzewiecki J, Eversley PJ et al. (2005) Phthalazinones, Part 1: the design and synthesis of a series of novel potential inhibitors of poly (ADP-ribose) polymerase. Bioorg. Med. Chem. Lett. 15, 2235-2238.
61. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ (2007) Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 6, 304-312.
62. John S, Nayvelt I, Hsu HC et al. (2008) Cancer cells regulation of estrogenic effects by Beclin 1 in breast. Cancer Res. 68, 7855-7863.